DOI . ORG {}

Matching Content Categories {📚}

• Education
• Health & Fitness
• Non-Profit & Charity

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don’t know how the website earns money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, google, scholar, cas, pubmed, patients, cancer, antibody, phase, study, conatumumab, advanced, receptor, tumors, human, solid, death, monoclonal, agonist, dose, access, apoptosis, ligand, tumor, nat, pancreatic, cell, trail, activity, privacy, cookies, content, japanese, fully, necrosis, meeting, abstracts, apoptosisinducing, japan, publish, search, doi, mgkg, pharmacokinetic, therapy, ashkenazi, gemcitabine, asco, clin, factorrelated,

Topics {✒️}

tumor-necrosis factor superfamily pitti rm anti-her3 monoclonal antibody month download article/chapter trail-mediated cell death monocyte-mediated tumoricidal activity advanced solid tumors anti-tumor activity related subjects therapy anti-tumor effect article cancer chemotherapy pancreatic cancer cells full article pdf pancreatic cancer model privacy choices/manage cookies evaluate receptor occupancy defective thymocyte apoptosis conatumumab receptor occupancy antibody pharmacokinetics trail-induced apoptosis trail apoptotic pathway advanced tumors starting dose level dose-limiting toxicities biologic correlative study death receptor 5 gemcitabine induce apoptosis phase ia trial targeting death receptors check access instant access cancer drug discovery european economic area scope submit manuscript synergistic cytotoxic effect wiley sr accelerated autoimmune diseases asco meeting abstracts conditions privacy policy apo-2 ligand adverse event leading human monocytes stimulated newcastle disease virus immune signaling networks tnf family phase 1 study agonist activity tumoricidal activity conatumumab administered intravenously

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
         description:Conatumumab is a fully human monoclonal agonist antibody against human death receptor 5 (DR5). The primary objectives of this phase 1 study were to assess the safety, tolerability, and pharmacokinetics (PK) of conatumumab in Japanese patients with advanced solid tumors. This is an open-label ascending dose study with a starting dose level of 3 mg/kg. Subsequent doses of 10 and 20 mg/kg were planned. Six patients were enrolled into 1 of 3 dose cohorts (3, 10, or 20 mg/kg) of conatumumab administered intravenously once every 2 weeks as a single agent. No conatumumab was administered on day 43 to allow the assessment of terminal PK parameters. The primary endpoints were the incidence of dose-limiting toxicities (DLTs) and assessment of PK parameters of conatumumab. Eighteen patients received at least 1 dose of conatumumab. There were no DLTs observed as defined in the protocol. No patients had an adverse event leading to conatumumab discontinuation. Conatumumab demonstrated dose-linear kinetics. A best response of stable disease was reported in nine patients. Monocytes were found to express DR5 and showed a high degree of conatumumab receptor occupancy after treatment at all dose levels. Conatumumab administered up to 20 mg/kg once every 2 weeks was well tolerated in Japanese patients with advanced solid tumors. Adverse events and PK in these patients were similar to those in the first in human (FIH) study.
         datePublished:2010-12-16T00:00:00Z
         dateModified:2010-12-16T00:00:00Z
         pageStart:733
         pageEnd:741
         sameAs:https://doi.org/10.1007/s00280-010-1544-1
         keywords:
            Conatumumab
            Advanced solid tumors
            Pharmacokinetics
            Phase 1 study
            Oncology
            Pharmacology/Toxicology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-010-1544-1/MediaObjects/280_2010_1544_Fig1_HTML.gif
         isPartOf:
            name:Cancer Chemotherapy and Pharmacology
            issn:
               1432-0843
               0344-5704
            volumeNumber:68
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:T. Doi
               affiliation:
                     name:National Cancer Center Hospital East
                     address:
                        name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:H. Murakami
               affiliation:
                     name:Shizuoka Cancer Center
                     address:
                        name:Shizuoka Cancer Center, Nagaizumi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. Ohtsu
               affiliation:
                     name:National Cancer Center Hospital East
                     address:
                        name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. Fuse
               affiliation:
                     name:National Cancer Center Hospital East
                     address:
                        name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Yoshino
               affiliation:
                     name:National Cancer Center Hospital East
                     address:
                        name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. Yamamoto
               affiliation:
                     name:Shizuoka Cancer Center
                     address:
                        name:Shizuoka Cancer Center, Nagaizumi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N. Boku
               affiliation:
                     name:Shizuoka Cancer Center
                     address:
                        name:Shizuoka Cancer Center, Nagaizumi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Y. Onozawa
               affiliation:
                     name:Shizuoka Cancer Center
                     address:
                        name:Shizuoka Cancer Center, Nagaizumi, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C-P. Hsu
               affiliation:
                     name:Amgen Inc.
                     address:
                        name:Amgen Inc., Thousand Oaks, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K. S. Gorski
               affiliation:
                     name:Amgen Inc.
                     address:
                        name:Amgen Inc., Thousand Oaks, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Friberg
               affiliation:
                     name:Amgen Inc.
                     address:
                        name:Amgen Inc., Thousand Oaks, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Kawaguchi
               affiliation:
                     name:Takeda Bio Development Center Ltd.
                     address:
                        name:Takeda Bio Development Center Ltd., Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Sasaki
               affiliation:
                     name:Takeda Bio Development Center Ltd.
                     address:
                        name:Takeda Bio Development Center Ltd., Tokyo, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phase 1 study of conatumumab, a pro-apoptotic death receptor 5 agonist antibody, in Japanese patients with advanced solid tumors
      description:Conatumumab is a fully human monoclonal agonist antibody against human death receptor 5 (DR5). The primary objectives of this phase 1 study were to assess the safety, tolerability, and pharmacokinetics (PK) of conatumumab in Japanese patients with advanced solid tumors. This is an open-label ascending dose study with a starting dose level of 3 mg/kg. Subsequent doses of 10 and 20 mg/kg were planned. Six patients were enrolled into 1 of 3 dose cohorts (3, 10, or 20 mg/kg) of conatumumab administered intravenously once every 2 weeks as a single agent. No conatumumab was administered on day 43 to allow the assessment of terminal PK parameters. The primary endpoints were the incidence of dose-limiting toxicities (DLTs) and assessment of PK parameters of conatumumab. Eighteen patients received at least 1 dose of conatumumab. There were no DLTs observed as defined in the protocol. No patients had an adverse event leading to conatumumab discontinuation. Conatumumab demonstrated dose-linear kinetics. A best response of stable disease was reported in nine patients. Monocytes were found to express DR5 and showed a high degree of conatumumab receptor occupancy after treatment at all dose levels. Conatumumab administered up to 20 mg/kg once every 2 weeks was well tolerated in Japanese patients with advanced solid tumors. Adverse events and PK in these patients were similar to those in the first in human (FIH) study.
      datePublished:2010-12-16T00:00:00Z
      dateModified:2010-12-16T00:00:00Z
      pageStart:733
      pageEnd:741
      sameAs:https://doi.org/10.1007/s00280-010-1544-1
      keywords:
         Conatumumab
         Advanced solid tumors
         Pharmacokinetics
         Phase 1 study
         Oncology
         Pharmacology/Toxicology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00280-010-1544-1/MediaObjects/280_2010_1544_Fig1_HTML.gif
      isPartOf:
         name:Cancer Chemotherapy and Pharmacology
         issn:
            1432-0843
            0344-5704
         volumeNumber:68
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:T. Doi
            affiliation:
                  name:National Cancer Center Hospital East
                  address:
                     name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:H. Murakami
            affiliation:
                  name:Shizuoka Cancer Center
                  address:
                     name:Shizuoka Cancer Center, Nagaizumi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. Ohtsu
            affiliation:
                  name:National Cancer Center Hospital East
                  address:
                     name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. Fuse
            affiliation:
                  name:National Cancer Center Hospital East
                  address:
                     name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Yoshino
            affiliation:
                  name:National Cancer Center Hospital East
                  address:
                     name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. Yamamoto
            affiliation:
                  name:Shizuoka Cancer Center
                  address:
                     name:Shizuoka Cancer Center, Nagaizumi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N. Boku
            affiliation:
                  name:Shizuoka Cancer Center
                  address:
                     name:Shizuoka Cancer Center, Nagaizumi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Y. Onozawa
            affiliation:
                  name:Shizuoka Cancer Center
                  address:
                     name:Shizuoka Cancer Center, Nagaizumi, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C-P. Hsu
            affiliation:
                  name:Amgen Inc.
                  address:
                     name:Amgen Inc., Thousand Oaks, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K. S. Gorski
            affiliation:
                  name:Amgen Inc.
                  address:
                     name:Amgen Inc., Thousand Oaks, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Friberg
            affiliation:
                  name:Amgen Inc.
                  address:
                     name:Amgen Inc., Thousand Oaks, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Kawaguchi
            affiliation:
                  name:Takeda Bio Development Center Ltd.
                  address:
                     name:Takeda Bio Development Center Ltd., Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Sasaki
            affiliation:
                  name:Takeda Bio Development Center Ltd.
                  address:
                     name:Takeda Bio Development Center Ltd., Tokyo, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Chemotherapy and Pharmacology
      issn:
         1432-0843
         0344-5704
      volumeNumber:68
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:National Cancer Center Hospital East
      address:
         name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
         type:PostalAddress
      name:Shizuoka Cancer Center
      address:
         name:Shizuoka Cancer Center, Nagaizumi, Japan
         type:PostalAddress
      name:National Cancer Center Hospital East
      address:
         name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
         type:PostalAddress
      name:National Cancer Center Hospital East
      address:
         name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
         type:PostalAddress
      name:National Cancer Center Hospital East
      address:
         name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
         type:PostalAddress
      name:Shizuoka Cancer Center
      address:
         name:Shizuoka Cancer Center, Nagaizumi, Japan
         type:PostalAddress
      name:Shizuoka Cancer Center
      address:
         name:Shizuoka Cancer Center, Nagaizumi, Japan
         type:PostalAddress
      name:Shizuoka Cancer Center
      address:
         name:Shizuoka Cancer Center, Nagaizumi, Japan
         type:PostalAddress
      name:Amgen Inc.
      address:
         name:Amgen Inc., Thousand Oaks, USA
         type:PostalAddress
      name:Amgen Inc.
      address:
         name:Amgen Inc., Thousand Oaks, USA
         type:PostalAddress
      name:Amgen Inc.
      address:
         name:Amgen Inc., Thousand Oaks, USA
         type:PostalAddress
      name:Takeda Bio Development Center Ltd.
      address:
         name:Takeda Bio Development Center Ltd., Tokyo, Japan
         type:PostalAddress
      name:Takeda Bio Development Center Ltd.
      address:
         name:Takeda Bio Development Center Ltd., Tokyo, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:T. Doi
      affiliation:
            name:National Cancer Center Hospital East
            address:
               name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:H. Murakami
      affiliation:
            name:Shizuoka Cancer Center
            address:
               name:Shizuoka Cancer Center, Nagaizumi, Japan
               type:PostalAddress
            type:Organization
      name:A. Ohtsu
      affiliation:
            name:National Cancer Center Hospital East
            address:
               name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:N. Fuse
      affiliation:
            name:National Cancer Center Hospital East
            address:
               name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:T. Yoshino
      affiliation:
            name:National Cancer Center Hospital East
            address:
               name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:N. Yamamoto
      affiliation:
            name:Shizuoka Cancer Center
            address:
               name:Shizuoka Cancer Center, Nagaizumi, Japan
               type:PostalAddress
            type:Organization
      name:N. Boku
      affiliation:
            name:Shizuoka Cancer Center
            address:
               name:Shizuoka Cancer Center, Nagaizumi, Japan
               type:PostalAddress
            type:Organization
      name:Y. Onozawa
      affiliation:
            name:Shizuoka Cancer Center
            address:
               name:Shizuoka Cancer Center, Nagaizumi, Japan
               type:PostalAddress
            type:Organization
      name:C-P. Hsu
      affiliation:
            name:Amgen Inc.
            address:
               name:Amgen Inc., Thousand Oaks, USA
               type:PostalAddress
            type:Organization
      name:K. S. Gorski
      affiliation:
            name:Amgen Inc.
            address:
               name:Amgen Inc., Thousand Oaks, USA
               type:PostalAddress
            type:Organization
      name:G. Friberg
      affiliation:
            name:Amgen Inc.
            address:
               name:Amgen Inc., Thousand Oaks, USA
               type:PostalAddress
            type:Organization
      name:T. Kawaguchi
      affiliation:
            name:Takeda Bio Development Center Ltd.
            address:
               name:Takeda Bio Development Center Ltd., Tokyo, Japan
               type:PostalAddress
            type:Organization
      name:T. Sasaki
      affiliation:
            name:Takeda Bio Development Center Ltd.
            address:
               name:Takeda Bio Development Center Ltd., Tokyo, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
      name:Shizuoka Cancer Center, Nagaizumi, Japan
      name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
      name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
      name:Gastrointestinal/Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
      name:Shizuoka Cancer Center, Nagaizumi, Japan
      name:Shizuoka Cancer Center, Nagaizumi, Japan
      name:Shizuoka Cancer Center, Nagaizumi, Japan
      name:Amgen Inc., Thousand Oaks, USA
      name:Amgen Inc., Thousand Oaks, USA
      name:Amgen Inc., Thousand Oaks, USA
      name:Takeda Bio Development Center Ltd., Tokyo, Japan
      name:Takeda Bio Development Center Ltd., Tokyo, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(189)

• How much profit does https://link.springer.com/privacystatement generate?
• Profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/#main
• How much does https://link.springer.com net monthly?
• What's the financial intake of https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s00280-010-1544-1?
• How much cash flow does https://link.springer.com/article/10.1007/s00280-010-1544-1/#eds-c-header-nav have monthly?
• What's the income of https://link.springer.com/journals/?
• Profit of https://www.springernature.com/gp/authors
• Discover the revenue of https://link.springernature.com/home/
• What's the revenue for https://link.springer.com/article/10.1007/s00280-010-1544-1/#eds-c-header-popup-search?
• https://order.springer.com/public/cart's revenue stream
• How much does https://link.springer.com/article/10.1007/s00280-010-1544-1/ generate monthly?
• Profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/journal/280
• How much does https://link.springer.com/article/10.1007/s00280-010-1544-1/#citeas pull in monthly?
• How much profit does https://link.springer.com/article/10.1007/s00280-010-1544-1/journal/280/aims-and-scope make?
• What's the monthly income of https://submission.springernature.com/new-submission/280/3?
• https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-T_-Doi-Aff1's total income per month
• https://link.springer.com/article/10.1007/s00280-010-1544-1/#Aff1's financial summary
• What's the profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-H_-Murakami-Aff2?
• How much does https://link.springer.com/article/10.1007/s00280-010-1544-1/#Aff2 make?
• What are the earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-A_-Ohtsu-Aff1?
• What's the revenue for https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-N_-Fuse-Aff1?
• How much income does https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-T_-Yoshino-Aff1 have?
• What's the revenue for https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-N_-Yamamoto-Aff2?
• What's the income of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-N_-Boku-Aff2?
• What are the total earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-Y_-Onozawa-Aff2?
• Earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-C_P_-Hsu-Aff3
• What is the monthly revenue of https://link.springer.com/article/10.1007/s00280-010-1544-1/#Aff3?
• What is the monthly revenue of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-K__S_-Gorski-Aff3?
• What's the total monthly financial gain of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-G_-Friberg-Aff3?
• What is the earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-T_-Kawaguchi-Aff4?
• What's the monthly money flow for https://link.springer.com/article/10.1007/s00280-010-1544-1/#Aff4?
• How much cash flow does https://link.springer.com/article/10.1007/s00280-010-1544-1/#auth-T_-Sasaki-Aff4 have monthly?
• How much revenue does https://link.springer.com/article/10.1007/s00280-010-1544-1/article/10.1007/s00280-010-1544-1/metrics produce monthly?
• How much does https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00280-010-1544-1 make?
• How much profit does https://link.springer.com/product/springer-plus generate?
• How much money does https://www.springernature.com/gp/librarians/licensing/agc/journals generate?
• Get to know what's the income of https://link.springer.com/10.1007/s00280-016-3154-z?fromPaywallRec=true
• What's the monthly money flow for https://link.springer.com/10.1007/s10637-017-0463-y?fromPaywallRec=true?
• How much does https://link.springer.com/10.1007/s10637-021-01145-y?fromPaywallRec=true earn?
• How much income does https://link.springer.com/article/10.1007/s00280-010-1544-1/subjects/antibody-fragment-therapy have?
• Get to know what's the income of https://link.springer.com/article/10.1007/s00280-010-1544-1/subjects/antibody-therapy
• https://link.springer.com/article/10.1007/s00280-010-1544-1/subjects/dosage-compensation's total income per month
• What is the earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/subjects/molecularly-targeted-therapy?
• https://link.springer.com/article/10.1007/s00280-010-1544-1/subjects/phase-iii-trials's revenue stream
• https://link.springer.com/article/10.1007/s00280-010-1544-1/subjects/targeted-therapies's total income per month
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8663110 earns monthly
• Profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DyaK28XjtlGjtrc%3D
• Monthly income for http://scholar.google.com/scholar_lookup?&title=Induction%20of%20apoptosis%20by%20Apo-2%20ligand%2C%20a%20new%20member%20of%20the%20tumor%20necrosis%20factor%20cytokine%20family&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.271.22.12687&volume=271&pages=12687-12690&publication_year=1996&author=Pitti%2CRM&author=Marsters%2CSA&author=Rupper%2CS
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8777713 earning monthly?
• What's the monthly money flow for https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DyaK28XhtF2iug%3D%3D?
• How much does http://scholar.google.com/scholar_lookup?&title=Identification%20and%20characterization%20of%20a%20new%20member%20of%20the%20TNF%20family%20that%20induces%20apoptosis&journal=Immunity&doi=10.1016%2F1074-7613%2895%2990057-8&volume=3&pages=673-682&publication_year=1995&author=Wiley%2CSR&author=Schooley%2CK&author=Smolak%2CPJ bring in each month?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Targeting%20death%20receptors%20in%20cancer%20with%20Apo2L%2FTRAIL&journal=Curr%20Opin%20Pharmacol&doi=10.1016%2Fj.coph.2004.02.006&volume=4&pages=333-339&publication_year=2004&author=Kelly%2CS&author=Ashkenazi%2CA
• How much revenue does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD2MXht1Witb7J generate?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Promoting%20apoptosis%20as%20a%20strategy%20for%20cancer%20drug%20discovery&journal=Nat%20Rev%20Can&doi=10.1038%2Fnrc1736&volume=5&pages=876-885&publication_year=2005&author=Fesik%2CSW?
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18089714?
• How much does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD2sXhsVCjsr3I earn?
• Revenue of http://scholar.google.com/scholar_lookup?&title=TRA-8%20anti-DR5%20monoclonal%20antibody%20and%20gemcitabine%20induce%20apoptosis%20and%20inhibit%20radiologically%20validated%20orthotropic%20pancreatic%20tumor%20growth&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-07-0299&volume=6&issue=12%20pt1&pages=3198-3207&publication_year=2007&author=DeRosier%2CLC&author=Vickers%2CSM&author=Zinn%2CKR
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17114015 income
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Treatment%20with%20gemcitabine%20and%20TRA-8%20anti-death%20receptor-5%20mAb%20reduces%20pancreatic%20adenocarcinoma%20cell%20viability%20in%20vitro%20and%20growth%20in%20vivo&journal=J%20Gastrointest%20Surg&doi=10.1016%2Fj.gassur.2006.08.007&volume=10&pages=1291-1300&publication_year=2006&author=DeRosier%2CLC&author=Huang%2CZQ&author=Sellers%2CJC bring in?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11451151's financial summary
• What is the monthly revenue of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:STN:280:DC%2BD38%2FitVCrtg%3D%3D?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Pancreatic%20adenocarcinoma%20cell%20lines%20show%20variable%20susceptibility%20to%20TRAIL-mediated%20cell%20death&journal=Pancreas&doi=10.1097%2F00006676-200107000-00011&volume=23&pages=72-79&publication_year=2001&author=Ibrahim%2CSM&author=Ringel%2CJ&author=Schmidt%2CC make?
• What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12680221?
• What are the earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD3sXislaqtrY%3D?
• Earnings of http://scholar.google.com/scholar_lookup?&title=Synergistic%20cytotoxic%20effect%20of%20TRAIL%20and%20gemcitabine%20in%20pancreatic%20cancer%20cells&journal=Anticancer%20Res&volume=23&pages=251-258&publication_year=2003&author=Xu%2CZW&author=Kleeff%2CJ&author=Friess%2CH
• Monthly income for https://link.springer.com/doi/10.1186/1479-5876-3-22
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15943879 earns monthly
• How much does http://scholar.google.com/scholar_lookup?&title=The%20anti-tumor%20effect%20of%20Apo2L%2FTRAIL%20on%20patient%20pancreatic%20adenocarcinomas%20grown%20as%20xenografts%20in%20SCID%20mice&journal=J%20Transl%20Med&doi=10.1186%2F1479-5876-3-22&volume=3&publication_year=2005&author=Hylander%2CBL&author=Pitoniak%2CR&author=Penetrante%2CRB generate monthly?
• Revenue of http://scholar.google.com/scholar_lookup?&title=First-in-human%20study%20of%20AMG%20655%2C%20a%20pro-apoptotic%20TRAIL%20receptor-2%20agonist%2C%20in%20adult%20patients%20with%20advanced%20solid%20tumors&journal=ASCO%20Meeting%20Abstracts&volume=25&publication_year=2007&author=LoRusso%2CP&author=Hong%2CD&author=Heath%2CE
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12189384?
• Learn about the earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD38Xksl2ltr4%3D
• How much does http://scholar.google.com/scholar_lookup?&title=Targeting%20death%20and%20decoy%20receptors%20of%20the%20tumor-necrosis%20factor%20superfamily&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc821&volume=2&issue=6&pages=420-430&publication_year=2002&author=Ashkenazi%2CA make?
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18813321
• What are the total earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD1cXhtFCrtbrM?
• Get to know http://scholar.google.com/scholar_lookup?&title=The%20TRAIL%20apoptotic%20pathway%20in%20cancer%20onset%2C%20progression%20and%20therapy&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc2465&volume=8&pages=782-798&publication_year=2008&author=Johnstone%2CRW&author=Frew%2CAJ&author=Smyth%2CMJ's earnings
• What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10411544?
• How much revenue does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DyaK1MXkslSmsbw%3D bring in?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Safety%20and%20antitumor%20activity%20of%20recombinant%20soluble%20Apo2%20ligand&journal=J%20Clin%20Invest&doi=10.1172%2FJCI6926&volume=104&pages=155-162&publication_year=1999&author=Ashkenazi%2CA&author=Pai%2CRC&author=Fong%2CS
• How much income does http://scholar.google.com/scholar_lookup?&title=AMG%20655%2C%20a%20fully%20human%20agonistic%20antibody%20against%20death%20receptor%205%2C%20enhances%20the%20anti-tumor%20activity%20of%20gemcitabine%20in%20MiaPaCa2%2FT2%2C%20a%20pancreatic%20cancer%20model&journal=AACR%20Meeting%20Abstracts&volume=49&publication_year=2008&author=Kaplan-Lefko%2CP&author=Bush%2CT&author=Belmontes%2CB have?
• What's the income generated by https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD1cXhsVKgu7bE each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Hypersensitivity%20to%20last%20generation%20chimeric%2C%20umanized%20and%20human%20recombinant%20monoclonal%20antibodies%20for%20therapeutic%20use&journal=Curr%20Pharmaceutical%20Design&doi=10.2174%2F138161208786369786&volume=14&pages=2883-2891&publication_year=2008&author=Calogiuri%2CG&author=Ventura%2CMT&author=Mason%2CL pull in monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20safety%20and%20pharmacokinetic%20study%20of%20Apomab%2C%20a%20human%20DR5%20agonist%20antibody%2C%20in%20patients%20with%20advanced%20cancer&journal=ASCO%20Meeting%20Abstracts&volume=25&publication_year=2007&author=Camidge%2CD&author=Herbst%2CRS&author=Gordon%2CM make?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17416859 generate?
• Revenue of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD2sXlt1Ghurg%3D
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Phase%20I%20pharmacokinetic%20and%20biologic%20correlative%20study%20of%20mapatumumab%2C%20a%20fully%20human%20monoclonal%20antibody%20with%20agonist%20activity%20to%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20receptor-1&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2006.08.8898&volume=25&pages=1390-1395&publication_year=2007&author=Tolcher%2CAW&author=Mita%2CM&author=Meropol%2CNJ produce monthly?
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17947486 generate?
• https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtFygsL%2FK's financial summary
• http://scholar.google.com/scholar_lookup?&title=Phase%201%20and%20pharmacokinetic%20study%20of%20lexatumumab%20in%20patients%20with%20advanced%20cancers&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-0950&volume=13&pages=6187-6194&publication_year=2007&author=Plummer%2CR&author=Attard%2CG&author=Pacey%2CS's revenue stream
• How much does http://scholar.google.com/scholar_lookup?&title=HGS-ETR2%E2%80%94A%20fully%20human%20monoclonal%20antibody%20to%20TRAIL-R2%3A%20results%20of%20a%20phase%20I%20trial%20in%20patients%20with%20advanced%20solid%20tumors&journal=ASCO%20Meeting%20Abstracts&volume=24&publication_year=2006&author=Patnaik%2CA&author=Wakelee%2CH&author=Mita%2CM gross monthly?
• What are the total earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD2cXpvV2isLk%3D?
• How much does http://scholar.google.com/scholar_lookup?&title=Antibody%20pharmacokinetics%20and%20pharmacodynamics&journal=J%20Pharmaceut%20Sci&doi=10.1002%2Fjps.20178&volume=93&pages=2645-2668&publication_year=2004&author=Lobo%2CED&author=Hansen%2CRJ&author=Balthasar%2CJP earn?
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10209050 have?
• What's the financial outcome of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DyaK1MXisF2hs78%3D?
• http://scholar.google.com/scholar_lookup?&title=Monocyte-mediated%20tumoricidal%20activity%20via%20the%20tumor%20necrosis%20factor-related%20cytokine%2C%20TRAIL&journal=J%20Exp%20Med&doi=10.1084%2Fjem.189.8.1343&volume=189&pages=1343-1353&publication_year=1999&author=Griffith%2CTS&author=Wiley%2CSR&author=Kubin%2CMZ income
• Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12574346
• How much money does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD3sXht12itLg%3D make?
• Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=TNF%20related%20apoptosis-inducing%20ligand%20mediates%20tumoricidal%20activity%20of%20human%20monocytes%20stimulated%20by%20Newcastle%20disease%20virus&journal=J%20Immunol&volume=170&pages=1814-1821&publication_year=2003&author=Washburn%2CB&author=Weigand%2CMA&author=Grosse-Wilds%2CA
• What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14688317?
• What is the monthly revenue of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD3sXpvFeht7w%3D?
• How much does http://scholar.google.com/scholar_lookup?&title=NK%20cell%20TRAIL%20eliminates%20immature%20dendritic%20cells%20in%20vivo%20and%20limits%20dendritic%20cell%20vaccination%20efficacy&journal=J%20Immunol&volume=172&pages=123-129&publication_year=2004&author=Hayakawa%2CY&author=Screpanti%2CV&author=Yagita%2CH pull in?
• How much revenue does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD1MXjtlymsLw%3D produce monthly?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Death%20receptor%20signal%20transducers%3A%20nodes%20of%20coordination%20in%20immune%20signaling%20networks&journal=Nat%20Immunology&doi=10.1038%2Fni.1714&volume=10&issue=4&pages=348-355&publication_year=2009&author=Wilson%2CNS&author=Dixit%2CV&author=Ashkenzi%2CA have monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9242611 produce monthly?
• How much does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DyaK2sXlt1eks78%3D make?
• How much profit does http://scholar.google.com/scholar_lookup?&title=Control%20of%20TRAIL-induced%20apoptosis%20by%20a%20family%20of%20signaling%20and%20decoy%20receptors&journal=Science&doi=10.1126%2Fscience.277.5327.818&volume=277&pages=818-821&publication_year=1997&author=Sheridan%2CJP&author=Marsters%2CSA&author=Pitti%2CRM make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9930862 pull in monthly?
• What's the income generated by https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DyaK1MXntlSrug%3D%3D each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Tumoricidal%20activity%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20in%20vivo&journal=Nat%20Med&doi=10.1038%2F5517&volume=5&issue=2&pages=157-163&publication_year=1999&author=Walczak%2CH&author=Miller%2CRE&author=Ariail%2CK earn?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11350907?
• What's the financial gain of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD3MXktlels78%3D?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Direct%20stimulation%20of%20apoptotic%20signaling%20by%20soluble%20Apo2L%2Ftumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20leads%20to%20selective%20killing%20of%20glioma%20cells&journal=Clin%20Cancer%20Res&volume=7&pages=1362-1369&publication_year=2001&author=Pollack%2CIF&author=Eriff%2CM&author=Ashkenazi%2CA?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12577054?
• What's the profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD3sXhsVGitr8%3D?
• Find out how much http://scholar.google.com/scholar_lookup?&title=Defective%20thymocyte%20apoptosis%20and%20accelerated%20autoimmune%20diseases%20in%20TRAIL%E2%88%92%2F%E2%88%92%20mice&journal=Nat%20Immunol&doi=10.1038%2Fni894&volume=4&pages=255-260&publication_year=2003&author=Lamhamedi-Cherradi%2CSE&author=Zheng%2CSJ&author=Maguschak%2CKA earns monthly
• Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11801676
• How much does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD38XpsFektw%3D%3D pull in?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Increased%20susceptibility%20to%20tumor%20initiation%20and%20metastasis%20in%20TNF-related%20apoptosis-inducing%20ligand-deficient%20mice&journal=J%20Immunol&volume=168&pages=1356-1361&publication_year=2002&author=Cretney%2CE&author=Takeda%2CK&author=Yagita%2CH each month?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15589175?
• How much revenue does https://link.springer.com/article/10.1007/s00280-010-1544-1/articles/cas-redirect/1:CAS:528:DC%2BD2MXjvFGjuw%3D%3D bring in?
• How much profit does http://scholar.google.com/scholar_lookup?&title=TRAIL-R%20as%20a%20negative%20regulator%20of%20innate%20immune%20cell%20responses&journal=Immunity&doi=10.1016%2Fj.immuni.2004.11.008&volume=21&pages=877-889&publication_year=2004&author=Diehl%2CGE&author=Yue%2CHH&author=Hsieh%2CK make?
• How much money does https://citation-needed.springer.com/v2/references/10.1007/s00280-010-1544-1?format=refman&flavour=references generate?
• What's the income of https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=T.%20Doi?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=T.%20Doi
• Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22T.%20Doi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
• How much does https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=H.%20Murakami pull in?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=H.%20Murakami?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22H.%20Murakami%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
• Revenue of https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=A.%20Ohtsu
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=A.%20Ohtsu generate?
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22A.%20Ohtsu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• How much profit is https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=N.%20Fuse making per month?
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Fuse?
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Fuse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• See how much https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=T.%20Yoshino makes per month
• What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=T.%20Yoshino each month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22T.%20Yoshino%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
• What's the financial gain of https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=N.%20Yamamoto?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Yamamoto?
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Yamamoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much cash flow does https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=N.%20Boku have monthly?
• Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=N.%20Boku
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22N.%20Boku%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
• Profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=Y.%20Onozawa
• How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Y.%20Onozawa have monthly?
• What's https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Y.%20Onozawa%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's gross income?
• How much money does https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=C-P.%20Hsu generate?
• Earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=C-P.%20Hsu
• What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22C-P.%20Hsu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• See how much https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=K.%20S.%20Gorski makes per month
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=K.%20S.%20Gorski pull in monthly?
• Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22K.%20S.%20Gorski%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the total monthly financial gain of https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=G.%20Friberg?
• What's the financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=G.%20Friberg?
• What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22G.%20Friberg%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=T.%20Kawaguchi
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=T.%20Kawaguchi net monthly?
• https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22T.%20Kawaguchi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
• See how much https://link.springer.com/article/10.1007/s00280-010-1544-1/search?sortBy=newestFirst&dc.creator=T.%20Sasaki makes per month
• https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=T.%20Sasaki income
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22T.%20Sasaki%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What is the earnings of https://link.springer.com/article/10.1007/s00280-010-1544-1/mailto:[email protected]?
• Get to know https://s100.copyright.com/AppDispatchServlet?title=Phase%201%20study%20of%20conatumumab%2C%20a%20pro-apoptotic%20death%20receptor%205%20agonist%20antibody%2C%20in%20Japanese%20patients%20with%20advanced%20solid%20tumors&author=T.%20Doi%20et%20al&contentID=10.1007%2Fs00280-010-1544-1©right=Springer-Verlag&publication=0344-5704&publicationDate=2010-12-16&publisherName=SpringerNature&orderBeanReset=true's earnings
• How much income is https://citation-needed.springer.com/v2/references/10.1007/s00280-010-1544-1?format=refman&flavour=citation earning monthly?
• How much revenue does https://link.springer.com/article/10.1007/s00280-010-1544-1/search?query=Conatumumab&facet-discipline="Medicine%20%26%20Public%20Health" produce monthly?
• What's the profit of https://link.springer.com/article/10.1007/s00280-010-1544-1/search?query=Advanced%20solid%20tumors&facet-discipline="Medicine%20%26%20Public%20Health"?
• See how much https://link.springer.com/article/10.1007/s00280-010-1544-1/search?query=Pharmacokinetics&facet-discipline="Medicine%20%26%20Public%20Health" makes per month
• How much revenue does https://link.springer.com/article/10.1007/s00280-010-1544-1/search?query=Phase%201%20study&facet-discipline="Medicine%20%26%20Public%20Health" bring in?
• How much does https://link.springer.com/journals/a/1 generate monthly?
• Check the income stats for https://link.springer.com/books/a/1
• What's the revenue for https://link.springer.com/journals?
• https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's financial summary
• How much does https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research bring in each month?
• https://www.springernature.com/gp/products income
• Get to know what's the income of https://www.springernature.com/gp/librarians
• How much revenue does https://www.springernature.com/gp/societies bring in?
• What's the profit of https://www.springernature.com/gp/partners?
• How much does https://www.springer.com/ pull in monthly?
• What's the revenue for https://www.nature.com/?
• What are the earnings of https://www.biomedcentral.com/?
• https://www.palgrave.com/'s total income per month
• What is the monthly revenue of https://www.apress.com/?
• How profitable is https://link.springer.com/brands/discover?
• What's the profit of https://www.springernature.com/gp/legal/ccpa?
• Revenue of https://www.springernature.com/gp/info/accessibility
• What's the financial gain of https://link.springer.com/termsandconditions?
• Revenue of https://support.springernature.com/en/support/home
• Learn about the earnings of https://link.springer.com/legal-notice
• Learn about the earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
• How much profit does https://www.springernature.com/ generate?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mx.zoho.eu
• mx2.zoho.eu
• mx3.zoho.eu

Name Servers:

• josh.ns.cloudflare.com
• zita.ns.cloudflare.com

CDN Services {📦}

• Crossref